Biotransformation of genistein and bisphenol A in cell lines used for screening endocrine disruptors

Toxicology in Vitro

Volumn 22, Issue 6, 2008, Pages 1595-1604

  Bursztyka, J ^c   Perdu, E ^c   Pettersson, K ^a   Pongratz, I ^a   Fernandez Cabrera M ^b   Olea, N ^b   Debrauwer, L ^c   Zalko, D ^c   Cravedi, J P ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF GRANADA   (Spain)

^c CNRS   (France)

Author keywords

Bisphenol A; Cell lines; Endocrine disruptors; Genistein; HC11; HepG2; MCF7; Metabolism; Toxicology

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ENDOCRINE DISRUPTOR; GENISTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; CELL LINE; CELL STRAIN MCF 7; DRUG ACTIVITY; HC11 CELL; HEPG2 CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; MOUSE; NONHUMAN; SCREENING;

ANIMALS; CELL LINE; CELL LINE, TUMOR; ENDOCRINE DISRUPTORS; GENISTEIN; GLUCURONATES; HUMANS; LIVER; MALE; MICE; MODELS, BIOLOGICAL; PHENOLS; RATS; RATS, WISTAR; SULFATES; TIME FACTORS;

RATTUS;

EID: 49349111264     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2008.06.013     Document Type: Article

References (65)

1. Biau S., Bayle S., de Santa Barbara P., and Roig B. The chick embryo: an animal model for detection of the effects of hormonal compounds. Anal. Bioanal. Chem. 387 4 (2007) 1397-1403
2. Brandon E.F., Bosch T.M., Deenen M.J., Levink R., van der Wal E., van Meerveld J.B., Bijl M., Beijnen J.H., Schellens J.H., and Meijerman I. Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines. Toxicol. Appl. Pharmacol. 211 1 (2006) 1-10
3. Breinholt V., and Larsen J.C. Detection of weak estrogenic flavonoids using a recombinant yeast strain and a modified MCF7 cell proliferation assay. Chem. Res. Toxicol. 11 6 (1998) 622-629
4. Brooks J.D., and Thompson L.U. Mammalian lignans and genistein decrease the activities of aromatase and 17beta-hydroxysteroid dehydrogenase in MCF-7 cells. J. Steroid. Biochem. Mol. Biol. 94 5 (2005) 461-467
5. Bursztyka J., Perdu E., Tulliez J., Debrauwer L., Delous G., Canlet C., De Sousa G., Rahmani R., Benfenati E., and Cravedi J.P. Comparison of genistein metabolism in rats and humans using liver microsomes and hepatocytes. Food. Chem. Toxicol. 46 3 (2007) 939-948
6. Buterin T., Koch C., and Naegeli H. Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells. Carcinogenesis 27 8 (2006) 1567-1578
7. Charles G.D. In vitro models in endocrine disruptor screening. ILAR J. 45 4 (2004) 494-501
8. Chen J.Q., Delannoy M., Cooke C., and Yager J.D. Mitochondrial localization of ERalpha and ERbeta in human MCF7 cells. Am. J. Physiol. Endocrinol. Metab. 286 6 (2004) E1011-E1022
9. Chen W.F., Huang M.H., Tzang C.H., Yang M., and Wong M.S. Inhibitory actions of genistein in human breast cancer (MCF-7) cells. Biochim. Biophys. Acta. 1638 2 (2003) 187-196
10. Chodon D., Ramamurty N., and Sakthisekaran D. Preliminary studies on induction of apoptosis by genistein on HepG2 cell line. Toxicol. In Vitro 21 5 (2007) 887-891
11. Coldham N.G., Howells L.C., Santi A., Montesissa C., Langlais C., King L.J., Macpherson D.D., and Sauer M.J. Biotransformation of genistein in the rat: elucidation of metabolite structure by product ion mass fragmentology. J. Steroid. Biochem. Mol. Biol. 70 4-6 (1999) 169-184
12. Constantinou A.I., Krygier A.E., and Mehta R.R. Genistein induces maturation of cultured human breast cancer cells and prevents tumor growth in nude mice. Am. J. Clin. Nutr. 68 Suppl 6 (1998) 1426S-1430S
13. Dogterom P. Development of a simple incubation system for metabolism studies with precision-cut liver slices. Drug. Metab. Dispos. 21 4 (1993) 699-704
14. Ekins S., Murray G.I., Burke M.D., Williams J.A., Marchant N.C., and Hawksworth G.M. Quantitative differences in phase I and II metabolism between rat precision-cut liver slices and isolated hepatocytes. Drug. Metab. Dispos. 23 11 (1995) 1274-1279
15. Ekins S., Williams J.A., Murray G.I., Burke M.D., Marchant N.C., Engeset J., and Hawksworth G.M. Xenobiotic metabolism in rat, dog, and human precision-cut liver slices, freshly isolated hepatocytes, and vitrified precision-cut liver slices. Drug. Metab. Dispos. 24 9 (1996) 990-995
16. Fang N., Yu S., and Badger T.M. Characterization of isoflavones and their conjugates in female rat urine using LC/MS/MS. J. Agric. Food. Chem. 50 9 (2002) 2700-2707
17. Faulds M.H., Olsen H., Helguero L.A., Gustafsson J.A., and Haldosen L.A. Estrogen receptor functional activity changes during differentiation of mammary epithelial cells. Mol. Endocrinol. 18 2 (2004) 412-421
18. Gelbke H.P., Kayser M., and Poole A. OECD test strategies and methods for endocrine disruptors. Toxicology 205 1-2 (2004) 17-25
19. Gould J.C., Leonard L.S., Maness S.C., Wagner B.L., Conner K., Zacharewski T., Safe S., McDonnell D.P., and Gaido K.W. Bisphenol A interacts with the estrogen receptor alpha in a distinct manner from estradiol. Mol. Cell. Endocrinol. 142 1-2 (1998) 203-214
20. Gray L.E., Ostby J., Wilson V., Lambright C., Bobseine K., Hartig P., Hotchkiss A., Wolf C., Furr J., Price M., Parks L., Cooper R.L., Stoker T.E., Laws S.C., Degitz S.J., Jensen K.M., Kahl M.D., Korte J.J., Makynen E.A., Tietge E.A., and Ankley G.T. Xenoendocrine disrupters-tiered screening and testing: filling key data gaps. Toxicology 181-182 (2002) 371-382
21. Gutendorf B., and Westendorf J. Comparison of an array of in vitro assays for the assessment of the estrogenic potential of natural and synthetic estrogens, phytoestrogens and xenoestrogens. Toxicology 166 1-2 (2001) 79-89
22. Harrington W.R., Sengupta S., and Katzenellenbogen B.S. Estrogen regulation of the glucuronidation enzyme UGT2B15 in estrogen receptor-positive breast cancer cells. Endocrinology 147 8 (2006) 3843-3850
23. Hashimoto Y., Moriguchi Y., Oshima H., Kawaguchi M., Miyazaki K., and Nakamura M. Measurement of estrogenic activity of chemicals for the development of new dental polymers. Toxicol. In Vitro 15 4-5 (2001) 421-425
24. Helguero L.A., Faulds M.H., Gustafsson J.A., and Haldosen L.A. Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene 24 44 (2005) 6605-6616
25. Hewitt N.J., and Hewitt P. Phase I and II enzyme characterization of two sources of HepG2 cell lines. Xenobiotica 34 3 (2004) 243-256
26. Hiroi H., Tsutsumi O., Momoeda M., Takai Y., Osuga Y., and Taketani Y. Differential interactions of bisphenol A and 17beta-estradiol with estrogen receptor alpha (ERalpha) and ERbeta. Endocr. J. 46 6 (1999) 773-778
27. Holmes, P., Humfrey C., Scullion M., 2001.Appraisal of test methods for sex hormone dirupting chemicals. OECD Environmental Health and Safety publications. Series on Testing and Assessment no.21, Paris. ENV/JM/MONO(2002)8 .).
28. Kim S., Shin H.J., Kim S.Y., Kim J.H., Lee Y.S., Kim D.H., and Lee M.O. Genistein enhances expression of genes involved in fatty acid catabolism through-activation of PPARalpha. Mol. Cell. Endocrinol. 220 1-2 (2004) 51-58
29. Kinjo J., Tsuchihashi R., Morito K., Hirose T., Aomori T., Nagao T., Okabe H., Nohara T., and Masamune Y. Interactions of phytoestrogens with estrogen receptors alpha and beta (III). Estrogenic activities of soy isoflavone aglycones and their metabolites isolated from human urine. Biol. Pharm. Bull. 27 2 (2004) 185-188
30. Krumdieck C.L., dos Santos J.E., and Ho K.J. A new instrument for the rapid preparation of tissue slices. Anal. Biochem. 104 1 (1980) 118-123
31. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., and Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138 3 (1997) 863-870
32. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., and Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139 10 (1998) 4252-4263
33. Kurosawa T., Hiroi H., Tsutsumi O., Ishikawa T., Osuga Y., Fujiwara T., Inoue S., Muramatsu M., Momoeda M., and Taketani Y. The activity of bisphenol A depends on both the estrogen receptor subtype and the cell type. Endocr. J. 49 4 (2002) 465-471
34. Leffers H., Naesby M., Vendelbo B., Skakkebaek N.E., and Jorgensen M. Estrogenic potencies of Zeranol, oestradiol, diethylstilboestrol, Bisphenol-A and genistein: implications for exposure assessment of potential endocrine disrupters. Hum.Reprod. 16 5 (2001) 1037-1045
35. Loukovaara M., Carson M., Palotie A., and Adlercreutz H. Regulation of sex hormone-binding globulin production by isoflavonoids and patterns of isoflavonoid conjugation in HepG2 cell cultures. Steroids 60 9 (1995) 656-661
36. Maggiolini M., Bonofiglio D., Marsico S., Panno M.L., Cenni B., Picard D., and Ando S. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol. Pharmacol. 60 3 (2001) 595-602
37. Matsumura A., Ghosh A., Pope G.S., and Darbre P.D. Comparative study of estrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. J. Steroid. Biochem. Mol. Biol. 94 5 (2005) 431-443
38. Matthews J.B., Twomey K., and Zacharewski T.R. In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors alpha and beta. Chem. Res. Toxico. 14 2 (2001) 149-157
39. Murata M., Midorikawa K., Koh M., Umezawa K., and Kawanishi S. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs. Biochemistry 43 9 (2004) 2569-2577
40. Nakagawa Y., and Suzuki T. Metabolism of 2-hydroxy-4-mthoxybenzophenone in isolated rat hepatocytes and xenoestrogenic effects of its metabolites on MCF-7 human breast cancer cells. Chem. Biol. Interact. 139 (2002) 115-128
41. OECD. The use of metabolising systems for in vitro testing of endocrine disruptors (www.oecd.org), 2006.
42. Olea N., Pulgar R., Perez P., OleaSerrano F., Rivas A., NovilloFertrell A., Pedraza V., Soto A.M., and Sonnenschein C. Estrogenicity of resin-based composites and sealants used in dentistry. Environ. Health Perspect. 104 3 (1996) 298-305
43. Parrish A.R., Gandolfi A.J., and Brendel K. Precision-cut tissue slices: applications in pharmacology and toxicology. Life Sci. 57 21 (1995) 1887-1901
44. Pfeiffer E., and Metzler M. Effect of bisphenol A on drug metabolising enzymes in rat hepatic microsomes and precision-cut rat liver slices. Arch. Toxicol. 78 7 (2004) 369-377
45. Reel J.R., Lamb J.C., and Neal B.H. Survey and assessment of mammalian estrogen biological assays for hazard characterization. Fund. Appl. Toxicol. 34 2 (1996) 288-305
46. Rivas A., Lacroix M., Olea-Serrano F., Laios I., Leclercq G., and Olea N. Estrogenic effect of a series of bisphenol analogues on gene and protein expression in MCF-7 breast cancer cells. J. Steroid. Biochem. Mol. Biol. 82 1 (2002) 45-53
47. Roberts-Kirchhoff E.S., Crowley J.R., Hollenberg P.F., and Kim H. Metabolism of genistein by rat and human cytochrome P450s. Chem. Res. Toxicol. 12 7 (1999) 610-616
48. Safe S.H., Pallaroni L., Yoon K., Gaido K., Ross S., and McDonnell D. Problems for risk assessment of endocrine-active estrogenic compounds. Environ. Health Perspect. 110 Suppl 6 (2002) 925-929
49. Shimizu M., Ohta K., Matsumoto Y., Fukuoka M., Ohno Y., and Ozawa S. Sulfation of bisphenol A abolished its estrogenicity based on proliferation and gene expression in human breast cancer MCF-7 cells. Toxicol. In Vitro 16 5 (2002) 549-556
50. Snyder R.W., Maness S.C., Gaido K.W., Welsch F., Sumner S.C., and Fennell T.R. Metabolism and disposition of bisphenol A in female rats. Toxicol. Appl. Pharmacol. 168 3 (2000) 225-234
51. Solakidi S., Psarra A.M., and Sekeris C.E. Differential subcellular distribution of estrogen receptor isoforms: localization of ERalpha in the nucleoli and ERbeta in the mitochondria of human osteosarcoma SaOS-2 and hepatocarcinoma HepG2 cell lines. Biochim. Biophys. Acta. 1745 3 (2005) 382-392
52. Soto A.M., and Sonnenschein C. The role of estrogens on the proliferation of human breast tumor cells (MCF-7). J. Steroid. Biochem. 23 1 (1985) 87-94
53. Soto A.M., Sonnenschein C., Chung K.L., Fernandez M.F., Olea N., and Serrano F.O. The E-SCREEN assay as a tool to identify estrogens: an update on estrogenic environmental pollutants. Environ. Health Perspect. 103 Suppl 7 (1995) 13-22
54. Spink B.C., Katz B.H., Hussain M.M., Pang S., Connor S.P., Aldous K.M., Gierthy J.F., and Spink D.C. SULT1A1 catalyzes 2-methoxyestradiol sulfonation in MCF-7 breast cancer cells. Carcinogenesis 21 11 (2000) 1947-1957
55. Spink D.C., Spink B.C., Cao J.Q., DePasquale J.A., Pentecost B.T., Fasco M.J., Li Y., and Sutter T.R. Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 19 2 (1998) 291-298
56. Sumida K., Ooe N., Nagahori H., Saito K., Isobe N., Kaneko H., and Nakatsuka I. An in vitro reporter gene assay method incorporating metabolic activation with human and rat S9 or liver microsomes. Biochem. Biophys. Res. Commun. 280 1 (2001) 85-91
57. Vivacqua A., Recchia A.G., Fasanella G., Gabriele S., Carpino A., Rago V., Di Gioia M.L., Leggio A., Bonofiglio D., Liguori A., and Maggiolini M. The food contaminants bisphenol A and 4-nonylphenol act as agonists for estrogen receptor alpha in MCF7 breast cancer cells. Endocrine 22 3 (2003) 275-284
58. Westerink W.M., and Schoonen W.G. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Toxicol. In Vitro. (2007)
59. Westerink W.M., and Schoonen W.G. Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Toxicol. In Vitro. (2007)
60. Wilkening S., and Bader A. Influence of culture time on the expression of drug-metabolizing enzymes in primary human hepatocytes and hepatoma cell line HepG2. J. Biochem. Mol. Toxicol. 17 4 (2003) 207-213
61. Yoon K., Pallaroni L., Stoner M., Gaido K., and Safe S. Differential activation of wild-type and variant forms of estrogen receptor alpha by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements. J. Steroid. Biochem. Mol. Biol. 78 1 (2001) 25-32
62. Yoshihara S., Makishima M., Suzuki N., and Ohta S. Metabolic activation of bisphenol A by rat liver S9 fraction. Toxicol. Sci. 62 2 (2001) 221-227
63. Yoshihara S., Mizutare T., Makishima M., Suzuki N., Fujimoto N., Igarashi K., and Ohta S. Potent estrogenic metabolites of bisphenol A and bisphenol B formed by rat liver S9 fraction: their structures and estrogenic potency. Toxicol. Sci. 78 1 (2004) 50-59
64. Zalko D., Perdu-Durand E., Debrauwer L., Bec-Ferte M.P., and Tulliez J. Comparative metabolism of clenbuterol by rat and bovine liver microsomes and slices. Drug. Metab. Dispos. 26 1 (1998) 28-35
65. Zalko D., Soto A.M., Dolo L., Dorio C., Rathahao E., Debrauwer L., Faure R., and Cravedi J.P. Biotransformations of bisphenol A in a mammalian model: answers and new questions raised by low-dose metabolic fate studies in pregnant CD1 mice. Environ. Health Perspect. 111 3 (2003) 309-319